Effects of repeated administration of selective adenosine A(1) and A(2A) receptor agonists on pentylenetetrazole-induced convulsions in the rat

被引:48
作者
Adami, M
Bertorelli, R
Ferri, N
Foddi, MC
Ongini, E
机构
[1] Research Laboratories, Schering-Plough, Milan, Comazzo
关键词
adenosine receptor; adenosine A(1) receptor agonist; adenosine A(2A) receptor agonist; seizure; pentylenetetrazole; (rat);
D O I
10.1016/0014-2999(95)00557-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The protective effects of the selective adenosine A, receptor agonist, 2-chloro-N-6-cyclopentyladenosine (CCPA), the selective adenosine A(2A) receptor agonist, 2-hexynyl-5'-N-ethylcarboxamidoadenosine (2HE-NECA), and the non-selective agonist, 5'-N-ethylcarboxamidoadenosine (NECA) were studied against lethal seizures induced by intraperitoneal (i.p.) injection of pentylenetetrazole (80 mg/kg). In acute studies there was a dose-dependent reduction of lethal seizures, as shown by the low dose's protecting 50% of animals (PD50): 0.11, 0.05 and 0.05 mg/kg i.p. for CCPA, 2HE-NECA and NECA, respectively. In the repeated administration studies the animals received either vehicle or drug i.p. twice daily for 12 days. The drug doses were twice the PD50 value: 0.3 mg/kg for CCPA or 0.1 mg/kg for both 2HE-NECA and NECA. 2HE-NECA and NECA maintained their protective activity against pentylenetetrazole-induced seizures (63% or 60% vs. 60% or 58% in acute studies, respectively). Conversely, repeated treatment with CCPA resulted in a marked decrease of its effects (67% vs. 30% in acute studies; P < 0.05). The data indicate that in addition to adenosine A(1) the A(2A) receptors also appear to be involved in the protection from seizures. The anticonvulsant effects induced by repeated stimulation of adenosine A(1) receptors are subject to tolerance, whereas effects depending on adenosine A(2A) receptor activation are maintained.
引用
收藏
页码:383 / 389
页数:7
相关论文
共 44 条
  • [1] PROLONGED AGONIST EXPOSURE INDUCES IMBALANCE OF A1 AND A2 RECEPTOR-MEDIATED FUNCTIONS IN RAT-BRAIN SLICES
    ABBRACCHIO, MP
    BRAMBILLA, R
    ROVATI, GE
    CATTABENI, F
    [J]. DRUG DEVELOPMENT RESEARCH, 1993, 28 (03) : 364 - 368
  • [2] BERMAN RF, 1990, KINDLING, V4, P423
  • [3] CENTRAL VERSUS PERIPHERAL MEDIATION OF RESPONSES TO ADENOSINE RECEPTOR AGONISTS - EVIDENCE AGAINST A CENTRAL MODE OF ACTION
    BRODIE, MS
    LEE, K
    FREDHOLM, BB
    STAHLE, L
    DUNWIDDIE, TV
    [J]. BRAIN RESEARCH, 1987, 415 (02) : 323 - 330
  • [4] ADENOSINE RECEPTORS IN BRAIN MEMBRANES - BINDING OF N6-CYCLOHEXYL[H-3]ADENOSINE AND 1,3-DIETHYL-8-[H-3]PHENYLXANTHINE
    BRUNS, RF
    DALY, JW
    SNYDER, SH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (09): : 5547 - 5551
  • [5] BRUNS RF, 1986, MOL PHARMACOL, V29, P331
  • [6] CASATI C, 1994, J PHARMACOL EXP THER, V268, P1506
  • [7] CONCAS A, 1993, J PHARMACOL EXP THER, V267, P844
  • [8] ADENOSINE DECREASES ASPARTATE AND GLUTAMATE RELEASE FROM RAT HIPPOCAMPAL SLICES
    CORRADETTI, R
    CONTE, GL
    MORONI, F
    PASSANI, MB
    PEPEU, G
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 104 (1-2) : 19 - 26
  • [9] 2-ALKYNYL DERIVATIVES OF ADENOSINE AND ADENOSINE-5'-N-ETHYLURONAMIDE AS SELECTIVE AGONISTS AT A2 ADENOSINE RECEPTORS
    CRISTALLI, G
    ELEUTERI, A
    VITTORI, S
    VOLPINI, R
    LOHSE, MJ
    KLOTZ, KN
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (13) : 2363 - 2368
  • [10] IS ADENOSINE AN ENDOGENOUS ANTICONVULSANT
    DRAGUNOW, M
    GODDARD, GV
    LAVERTY, R
    [J]. EPILEPSIA, 1985, 26 (05) : 480 - 487